Li/sub 2/B/sub 4/O/sub 7/
Combination of PEI-Mn<sub>0.5</sub>Zn<sub>0.5</sub>Fe<sub>2</sub>O<sub>4</sub> nanoparticles and pHsp 70-<em>HSV</em>-<em>TK</em>/GCV with magnet-induced heating for treatment of hepatoma
... SEM examination revealed that the cells of control group and gene transfection-alone group have rather regular shape with intact nuclei, fine chromatin, and a large, clear nucleolus; and the characteristic features of ...
15
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... 3 O 4 @SiO 2 , which allows high efficient loading of VEGF small hairpin (sh)RNA to form Fe 3 O 4 @SiO 2 /PEI/VEGF shRNA nanocomposites for VEGF gene silencing as well as ...
13
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... After intragastric administration, 0.2–0.5 mL of blood from one mouse in each group were collected into an ethylene- diaminetetraacetic acid tube by enucleating eyeballs at the time points of zero minutes, hours 1, 3, 5, ...
6
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... 3 O 4 , Dex/Fe 3 O 4 , and Bis/Dex/Fe 3 O 4 was verified by XRD (Figure ...3 O 4 pattern published by ...3 O 4 and Bis/Dex/ Fe 3 O 4 was ...
12
Effect of Cobalt Precursors on Properties of Co/CoAl<sub>2</sub>O<sub>4</sub> Catalysts Synthesized by Solvothermal Method
... Many transition metals of Group VIII can be used as catalysts for FTS, such as iron (Fe), cobalt (Co), nickel (Ni), and ruthenium (Ru) [2-4]. However, supported cobalt catalysts are preferred for FTS ...
10
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... Mice were randomly assigned to one of four groups (n = 10 per group). The doses of 5.14 mg/kg (low dose group), 20.7 mg/kg (medium dose group), and 51.4 mg/kg (high dose group) Fe 3 O 4 -MNPs, were ...
7
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... m O n -SiO 2 composite flake-like, and SiO 2 -Fe m O n core-shell IONPs on cell viability, function, and mor- phology were tested 48 h postincubation in human umbilical vein endothelial cell ...
11
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... 3 O 4 @SiO 2 modified with anti-mesothelin antibody (A-MFS) was prepared to target cells and tumor tissues highly expressing mesothelin in vitro (human pancreatic cancer cell line SW1990) and in vivo ...
13
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... different pH levels which are similar to the pH of the stomach and the pH of the blood. Generally, the pH of the stomach varies from 1–2 to 4–5. After eating, the stomach releases proteases and hydrochloric ...
12
Reactivity of Au/La<sub>1 x</sub>Sr<sub>x</sub>Cr<sub>1 y</sub>Ni<sub>y</sub>O<sub>3 δ</sub> toward Oxidative Coupling of Methane for C<sub>2</sub> and C<sub>3</sub> Hydrocarbons Production
... approach for reducing the total cost of electricity generation [5-7]. It is well established that the use of suitable catalyst at the electrode of SOFC is the key issue for achieving the good SOFC cogeneration ...
12
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... 3 O 4 nanoparticles were biocompatible and suitable for biomedi- cal ...3 O 4 was treated with low temperature intermittent sterilization, and RPMI 1640 culture medium containing 10% calf ...
10
Effect of plant extracts on H<sub>2</sub>O<sub>2</sub>-induced inflammatory gene expression in macrophages
... H 2 O 2 concentration in extracellular fluids during inflammatory processes are sufficient to activate the NF k B pathway, thereby allowing induction of the synthesis of cytokines and other ...
10
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... Notes: (A) cell viability of l929 cells incubated with different concentrations (10 µM, 1 µM, and 100 nM) of the gd-NPs for 24 and 48 hours. (B) apoptosis rates of Raw264.7 cells were measured by flow cytometry at ...
11
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... phase were cultured in 96-well flat-bottomed plates in a triplicate pattern and treated with different concentrations of ART, MNPs-Fe 3 O 4 , or the copolymer of ART with MNPs- Fe 3 O 4 in the ...
8
R<sub>2(GFR)</sub>CHADS<sub>2</sub> and R<sub>2(GFR)</sub>CHA<sub>2</sub>DS<sub>2</sub>VASc schemes improved the performance of CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
... Baseline characteristics were summarized as frequencies for categorical variables and median values with interquartile range for continuous variables. Cox regression model was used to explore whether renal function is a ...
6
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... = 4). Then, Fe 3 O 4 -PLGA or Fe 3 O 4 -PLGA-cRGD NPs at a final dosage of 1 mg lyophilized powder dissolving 1 mL phosphate- buffered saline (PBS) was administered to the rats by tail ...
14
Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle
... 3 O 4 adaptations in the face of elevated sympathetic nervous system ...3 O 4 has no significant influence on the expression profile of KCNQ 1 in rested or in exercised mice cardiac ...
8
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... 3 O 4 -MNP-DNR-5-BrTet and Fe 3 O 4 -MNP groups; karyopyknosis and karyorrhexis could be observed in the apoptotic cells, especially in the Fe 3 O 4 -MNP-DNR-5-BrTet ...3 ...
9
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... 3 O 4 (1 µ g/mL, 10 µ g/mL, or 100 µ g/mL) for 24 hours in the absence or presence of N-acetylcysteine (NAC; 10 mM) (Sigma-Aldrich Co); NAC was added 3 hours before treatment with MgNPs-Fe 3 O ...
10
<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>
... A burden of peripheral arterial disease (PAD) prevalence has been observed over the last decade. Globally in 2010, about 202 million people were diagnosed with PAD. 1 PAD is now the third most common cause of death from ...
16